These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 29942495)

  • 1. Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network.
    Sprangers B; Nair V; Launay-Vacher V; Riella LV; Jhaveri KD
    Clin Kidney J; 2018 Jun; 11(3):315-329. PubMed ID: 29942495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
    Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of malignancies after kidney transplantation in adults: Slovak multicenter experience.
    Zilinska Z; Sersenova M; Chrastina M; Breza J; Bena L; Baltesova T; Jurcina A; Roland R; Lackova E; Cellar M; Laca L; Dedinska I
    Neoplasma; 2017; 64(2):311-317. PubMed ID: 28052685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.
    Marcén R
    Drugs; 2009 Nov; 69(16):2227-43. PubMed ID: 19852526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancies in adult kidney transplant candidates and recipients: current status.
    Serkies K; Dębska-Ślizień A; Kowalczyk A; Lizakowski S; Małyszko J
    Nephrol Dial Transplant; 2023 Jun; 38(7):1591-1602. PubMed ID: 35998321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancies after pediatric kidney transplantation: more than PTLD?
    Mynarek M; Hussein K; Kreipe HH; Maecker-Kolhoff B
    Pediatr Nephrol; 2014 Sep; 29(9):1517-28. PubMed ID: 24061645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Immunosenescence in Older Kidney Transplant Recipients: Associated Clinical Outcomes and Possible Risk Stratification for Immunosuppression Reduction.
    Jallah BP; Kuypers DRJ
    Drugs Aging; 2024 Mar; 41(3):219-238. PubMed ID: 38386164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death after Kidney Transplantation: An Analysis by Era and Time Post-Transplant.
    Ying T; Shi B; Kelly PJ; Pilmore H; Clayton PA; Chadban SJ
    J Am Soc Nephrol; 2020 Dec; 31(12):2887-2899. PubMed ID: 32908001
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney Transplant Recipients Have Higher Malignancy Prevalence Than Hemodialyzed Patients.
    Pyrża M; Małyszko J; Głogowski T; Wieliczko M; Żebrowski P; Małyszko J
    Transplant Proc; 2022 May; 54(4):972-975. PubMed ID: 35282885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients.
    de Boer SE; Sanders JSF; Bemelman FJ; Betjes MGH; Burgerhof JGM; Hilbrands L; Kuypers D; van Munster BC; Nurmohamed SA; de Vries APJ; van Zuilen AD; Hesselink DA; Berger SP
    BMC Nephrol; 2021 Jun; 22(1):208. PubMed ID: 34078323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer - a population cohort study.
    Lim WH; Badve SV; Wong G
    Oncotarget; 2017 Sep; 8(44):77771-77782. PubMed ID: 29100424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy following renal transplantation.
    Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo noncutaneous malignancies after kidney transplantation are associated with an increased risk of graft failure: results from a time-dependent analysis on 672 patients.
    Cena T; Musetti C; Quaglia M; Magnani C; Stratta P; Bagnardi V; Cantaluppi V
    Transpl Int; 2016 Oct; 29(10):1085-93. PubMed ID: 27343849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Risk Factors of Post-renal Transplantation Malignancies in North of Iran, A 20-year Experience.
    Nejatifar F; Monfared A; Khosravi M; Lebadi M; Shakiba M; Mokhtari G; Aghajanzadeh P; Haghdar-Saheli Y; Movasaghi A; Ramezanzadeh E; Akhondzadeh L
    Iran J Kidney Dis; 2020 Dec; 14(6):439-447. PubMed ID: 33277447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing thrombosis in solid organ transplant recipients.
    Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.